Part 2: A Conversation on Updated Remdesivir Trials

Published by : Drug Topics
Julie Ann Justo, infectious diseases clinical pharmacist and associate professor at the University of South Carolina College of Pharmacy, discusses the latest data from Gilead's trials for Remdesivir, a potential COVID-19 treatment.
cached video